Clinical Trial Detail

NCT ID NCT03607643
Title A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Leaf Vertical Inc.
Indications

glioblastoma multiforme

gastrointestinal system cancer

multiple myeloma

Therapies

Temozolomide

Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Bevacizumab + Cannabidiol + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Bortezomib

Bortezomib + Cannabidiol

Cannabidiol + Gemcitabine

Cannabidiol + Temozolomide

Gemcitabine

Age Groups: adult senior

No variant requirements are available.